Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer

OBJECTIVES: Gonadotropin-releasing hormone agonists are widely used as androgen deprivation therapy in many men with locally advanced or metastatic prostate cancer. Gonadotropin-releasing hormone agonists are delivered by intramuscular injection every 1, 3 or 6 months, but in some patients subcutane...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ther Adv Urol
Huvudupphovsmän: Lebret, Thiery, Rouanne, Mathieu, Hublarov, Oleg, Jinga, Viorel, Petkova, Lidiya, Kotsev, Rumen, Sinescu, Ioanel, Dutailly, Pascale
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2015
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485417/
https://ncbi.nlm.nih.gov/pubmed/26161143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215577329
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk